Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 50 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 20 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; hyprolose; colloidal anhydrous silica; croscarmellose sodium; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - dasatinib, quantity: 70 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hyprolose; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; calcium hydrogen phosphate; titanium dioxide; hypromellose; triacetin - dasatinib sun is indicated for the treatment of adults aged 18 years or over with:,? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase.,? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib.,? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy.,? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib sun is indicated for the treatment of paediatric patients with:,? ph+ cml in the chronic phase.,? newly diagnosed ph+ all in combination with chemotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - ropinirole hydrochloride - film coated tablet - 0.5 milligram

Malta - English - Medicines Authority

the wellcome foundation 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - valaciclovir - film-coated tablet - valaciclovir 500 mg - antivirals for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

primecrown 2010 ltd - atovaquone, proguanil hydrochloride - film coated tablet - 250/100 milligram - biguanides

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - deferiprone, quantity: 500 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 3350; hypromellose; microcrystalline cellulose; silicon dioxide; magnesium stearate - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective.

Singapore - English - HSA (Health Sciences Authority)

duopharma (singapore) pte ltd - azithromycin dihydrate equivalent to azithromycin - tablet, film coated - azithromycin dihydrate equivalent to azithromycin 250.00 mg

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson pte. ltd. - canagliflozin hemihydrate 153.0mg eqv. to canagliflozin; metformin 779.88mg eqv to metformin hydrochloride - tablet, film coated - canagliflozin hemihydrate 153.0mg eqv. to canagliflozin 150.00 mg; metformin 779.88mg eqv to metformin hydrochloride 1000.00 mg

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson pte. ltd. - canagliflozin hemihydrate 153.0mg eqv. to canagliflozin; metformin 389.94mg eqv to metformin hydrochloride - tablet, film coated - canagliflozin hemihydrate 153.0mg eqv. to canagliflozin 150.00 mg; metformin 389.94mg eqv to metformin hydrochloride 500.00 mg